🔬9913 is a hippocampus stimulator that aims to enhance memory and potentially cure Alzheimer's.
💊The drug is being tested in a clinical drug trial, and participants are confined to a research facility.
🧠The drug stimulates the hippocampus, the part of the brain associated with memory.
📚Participants may receive a placebo, and the effects of the drug vary among individuals.
🚫Leaving the facility before the completion of the study is strictly forbidden for safety reasons.
What is 9913?
—9913 is a revolutionary memory enhancer that stimulates the hippocampus, the part of the brain associated with memory. It aims to improve memory and potentially cure Alzheimer's disease.
How does the clinical drug trial work?
—Participants in the drug trial are confined to a research facility and continuously monitored. They may receive 9913 or a placebo, and the effects of the drug vary among individuals.
What are the potential benefits of 9913?
—The potential benefits of 9913 include enhanced memory and the potential cure for Alzheimer's disease.
What are the risks of participating in the trial?
—The risks of participating in the trial include the possibility of receiving a placebo and the unknown effects of the drug on individuals.
Can participants leave the facility during the trial?
—No, leaving the facility before the completion of the study is strictly forbidden for safety reasons.
00:00A revolutionary memory enhancer called 9913 is being tested in a clinical drug trial.
07:57Participants in the drug trial are confined to a research facility and continuously monitored.
14:23The drug stimulates the hippocampus, the part of the brain associated with memory.
19:24The effects of the drug vary among individuals, and there is a 50% chance of receiving a placebo.
23:26Leaving the facility before the completion of the study is strictly forbidden for safety reasons.
